Princeton Global Asset Management LLC Kamada LTD Transaction History

Princeton Global Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$6.02 - $8.06 $9,030 - $12,090	-1,500 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$6.3 - $8.46 $3,150 - $4,230	-500 Reduced 25.0%	1,500 $10,000
Q3 2020 Oct 27, 2020	BUY	$8.02 - $11.73 $4,010 - $5,865	500 Added 33.33%	2,000 $17,000
Q2 2020 Aug 11, 2020	BUY	$5.37 - $9.45 $8,055 - $14,174	1,500 New	1,500 $11,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $271M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Global Asset Management LLC with notifications on news.